Evidence map›Paper›PMID 39113856›Full record

ArticleAmerican journal of cancer research2024

Circulating tumor cells in patients with cervical cancer undergoing chemoradiotherapy combined with brachytherapy.

Klaudia Reginacova, Eliska Pospisilova, Martina Kubecova, Pavla Svobodova, Vladimir Bobek, Katarina Kolostova

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of cancer research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Klaudia ReginacovaDepartment of Oncology, The Third Faculty of Medicine, Charles University Prague and Faculty Hospital Kralovske Vinohrady Srobarova 50, 100 34 Prague 10, Czech Republic.
Eliska PospisilovaLaboratory of Personalized Medicine, Oncology Clinic, Faculty Hospital Kralovske Vinohrady Srobarova 50, 100 34 Prague 10, Czech Republic.
Martina KubecovaDepartment of Oncology, The Third Faculty of Medicine, Charles University Prague and Faculty Hospital Kralovske Vinohrady Srobarova 50, 100 34 Prague 10, Czech Republic.
Pavla SvobodovaDepartment of Gynaecology, Military University Hospital and The Third Faculty of Medicine U Vojenske Nemocnice 1200, 169 02 Prague 6, Czech Republic.
Vladimir BobekLaboratory of Personalized Medicine, Oncology Clinic, Faculty Hospital Kralovske Vinohrady Srobarova 50, 100 34 Prague 10, Czech Republic.
Katarina KolostovaLaboratory of Personalized Medicine, Oncology Clinic, Faculty Hospital Kralovske Vinohrady Srobarova 50, 100 34 Prague 10, Czech Republic.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circulating tumor cells (CTCs) have significant potential to become an important tool for monitoring the effects of treatment in solid tumors. The present study reports the occurance of CTCs in cervical cancer (CC) patients during radical chemoradiotherapy (CRT), including brachytherapy (BRT), and during the follow-up period. Patients diagnosed with CC treated with radical CRT were included in the study (n=30). A total of 167 CTC-tests (MetaCell

Indexed as

brachytherapyCervical cancerchemoradiotherapycirculating tumor cellsCRTSCCstemness

Identifiers

PMID39113856
PMCPMC11301293

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.